Search review questions

Hostility BPRS hostility sub scale, CPRS hostility subscale, Q‐sort, speech content analysis (endpoints fall between 1 and 6 months) · Any individual experiencing recurrent aggressive outbursts or episodes

Anger Self‐reported outbursts, Rosenweig Picture Frustration Test (endpoints fall between 2 weeks and 6 months) · Any individual experiencing recurrent aggressive outbursts or episodes

Anger‐Hostility POMS anger‐hostility subscale (endpoints fall between 1 and 6 months) · Any individual experiencing recurrent aggressive outbursts or episodes

Non‐compliance leaving the study early (endpoints fall between 1 and 6 months) · Any individual experiencing recurrent aggressive outbursts or episodes

Adverse events, any (endpoints fall between 1 6 six months) · Any individual experiencing recurrent aggressive outbursts or episodes

Total score (using structured skills assessment) · patients with adults with low vision

All clinical conditions (binary outcomes)

All clinical conditions (continuous outcomes)

Pain [2] (continuous outcomes)

Nausea [2] (continuous outcomes) Â

Depression [2] (continuous outcomes)

Other outcomes [2] (continuous outcomes) Smoking, dementia, obesity, hypertension, insomnia, anxiety, asthma, phobia)

Immunisation schedule up to date Interviews with mothers, record reviews · patients with improving immunisation uptake among children < 2 years whose vaccination is not up to date

Completed preventive therapy with Isoniazid ‐ LHW supported self‐supervision or DOT compared with self‐supervision · patients with tuberculosis (TB) treatment

Initiation of breastfeeding Self‐report · patients with breastfeeding

Any breastfeeding Self‐report · patients with breastfeeding

Exclusive breastfeeding Self‐report · patients with breastfeeding

Mortality among children less than 5 years Verbal autopsy · patients with reducing mortality and morbidity in children <5 years

Morbidity e.g. fever, diarrhoea, ARI Verbal reports obtained during home visits, record reviews · patients with reducing mortality and morbidity in children <5 years

Neonatal Mortality verbal autopsy · patients with reducing mortality and morbidity in children <5 years

Morbidity ‐ care seeking practice hospital record review · patients with reducing mortality and morbidity in children <5 years

Cure for smear positive TB patients (new and retreatment) Sputum smear test · patients with tuberculosis (TB) treatment

asteric* denotes studies reporting both speed and crash outcomes.

A time halo effect lasted for 3 days following a single application of enforcement. With 5 days of consecutive enforcement a time halo of at least 6 days was noted. At the site of speed limit enforcement the average speed was reduced to around the...

2.8 km/h reduction in mean speed at monitoring site, 2km from experimental site.

Reductions in median speed by 40 km/h and 28km/h in left and middle car lanes and 23km/h in truck lane on autobahn, sustained through 10 years of continuous enforcement. Also reductions in 85th percentile speeds of 42 and 37km/h in car lanes and 3...

During pilot program an overall 2.4 km/h reduction in mean speed with only small differences between the 3 cities. A 10.4% reduction in proportion of drivers exceeding the speed limit and a 4.5% reduction in those exceeding the speed limit by 10km.

On 80 km/h sections an 8% reduction of speeding vehicles seen on experimental sites compared to control sites in year 1, with a further 2% decrease in year 2. On 100 km/h stretches a 5% reduction in number of speeders seen in year 1, with a furthe...

Reduction in mean speeds by an average of 4.4 mph, 85% percentile speed reduction of 5.9 mph and a 35% reduction in percentage over the speed limit. These reductions were comparable for all monitored lengths e.g. up to 250m, 500m and 1 km.

65% reduction in speeding vehicles in excess of 15km/h or more, over the speed limit.

Mean speed reduction of 4 km/h on experimental roads compared to 1.5 km/h on control roads. A 12% reduction in percentage of drivers over the allowed speed limit on experimental roads compared to 5% reduction on control roads.

Aggregation of data from the 4 roads in provinces (compared to phase 0) showed a reduction in average speed of 3km/h in phase 1 and 5km/h in phase 2, a reduction in 85 percentile speed of 3km/h in phase 1 and 8 km/h in phase 2. A reduction in prop...

Reduction in average speeds by 0.9 to 4.8 km/h for all times of day reported. 10% reduction in proportion of speeding drivers. A time halo effect of up to 8 weeks was shown.

About 70% reduction in speeding vehicles when police present. A time halo effect lasted at least 2 days.

Average reduction in mean speed 2.3 km/h (p = 0.05) at camera sites post 1st year. Average reduction in mean speeds 1.3 km/h (‐2.6 to 0.1)post 2nd year on experimental open roads

At the Scottsdale sites mean speeds decreased from 70 mph to about 65 mph. At the non‐Loop 101 sites (where no before data was available) mean speeds fluctuated between 68 and 69 mph. The proportion of vehicles in excess of the tolerated speed lim...

Mean speed at the 5 sites (where cameras were deployed) decreased by 10% (range 5% ‐18%) The proportion of drivers travelling > 10 mph above the speed limits declined by about 70% at locations with both warning signs and speed camera enforcement, ...

A 0.91mph significant reduction in mean speeds at experimental sites with a small insignificant reduction at control sites, 0.99mph significant reduction in 85th percentile speeds at experimental sites with a small insignificant reduction at contr...

A significant 14% reduction in mean speeds compared to control sites. The proportion of vehicles exceeding the speed limit by more than 10mph decreased by 82%.

23% crash reduction during the day and a 21% reduction at other times.

Aggregate changes in crashes showed an insignificant 19.7% reduction in all reported crashes with a 20.1% reduction in injury crashes and an 89.8% reduction in fatal crashes along camera segments.

A significant 11% reduction in total crashes outside of city. Estimated 31% reduction in fatal crashes.

Greatest crash reductions in areas within 2km of camera sites, with 31% (1100), 39% (2200), 19% (500) and 21% (1600) reductions estimated for hospitalisation, medically treated, other injury and non‐injury crashes respectively.

A significant 58% reduction in serious or fatal injury crashes.

Overall mean speed reduction of about 2‐3km/h seen at both experimental and control sites. Distance halo of up to 14km downstream was seen. Time halo for at least the day after enforcement.

An estimated 7% reduction in overall injuries, 10% reduction in serious injury, and a 13% reduction in fatal crashes was reported

A net reduction of 71.3 % (p = 0.064) in injury crashes up to and including 4 days after the presence of enforcement. A net reduction of 73.9% (p =0.045) on the day when a mix of overt/covert enforcement employed.

A 25% reduction in expected crash rate, 11% reduction in injury crashes and a 17% reduction in daytime crash fatalities.

A reduction of 16% (+/‐ 7%) in expected crashes along study corridor. A 2.8km/h reduction in mean speed at monitoring site.

Personal injury crash frequency reduced by a ratio of 1:1